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Abstract: In this study, a fluorescence resonance energy transfer (FRET)-based quantum 
dot (QD) immunoassay for detection and identification of Aspergillus amstelodami was 
developed. Biosensors were formed by conjugating QDs to IgG antibodies and incubating 
with quencher-labeled analytes; QD energy was transferred to the quencher species through 
FRET, resulting in diminished fluorescence from the QD donor. During a detection event, 
quencher-labeled  analytes  are  displaced  by  higher  affinity  target  analytes,  creating  a 
detectable fluorescence signal increase from the QD donor. Conjugation and the resulting 
antibody:QD  ratios  were  characterized  with  UV-Vis  spectroscopy  and  QuantiT  protein 
assay. The sensitivity of initial fluorescence experiments was compromised by inherent 
autofluorescence  of  mold  spores,  which  produced  low  signal-to-noise  and  inconsistent 
readings. Therefore, excitation wavelength, QD, and quencher were adjusted to provide 
optimal signal-to-noise over spore background. Affinities of anti-Aspergillus antibody for 
different  mold  species  were  estimated  with  sandwich  immunoassays,  which  identified  
A.  fumigatus  and  A.  amstelodami  for  use  as  quencher-labeled-  and  target-analytes, 
respectively.  The  optimized  displacement  immunoassay  detected  A.  amstelodami 
concentrations  as  low  as  10
3  spores/mL  in  five  minutes  or  less.  Additionally,  baseline 
fluorescence was produced in the presence of 10
5 CFU/mL heat-killed E. coli O157:H7, 
demonstrating high specificity. This sensing modality may be useful for identification and 
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detection of other biological threat agents, pending identification of suitable antibodies. 
Overall, these FRET-based QD-antibody biosensors represent a significant advancement in 
detection capabilities, offering sensitive and reliable detection of targets with applications 
in areas from biological terrorism defense to clinical analysis.  
Keywords:  Fluorescence  Resonance  Energy  Transfer  (FRET);  quantum  dot  (QD); 
displacement immunoassay; detection; biosensor; fluorescence; quenching; mold; fungi; 
spores 
 
1. Introduction 
Recent terrorist attacks have reminded us of the immediate risk that biothreat agents pose, as well as 
the need for fast and accurate detection methods. Fungal species and their mycotoxins are among the 
growing list of biothreat agents of interest [1]. Molds and fungi are known to cause many adverse 
effects on human health, whether through development of allergies, most commonly asthma or rhinitis; 
infection  of  the  body;  or  toxicity  [2].  Immunocompromised  individuals,  such  as  those  receiving 
immunosuppressive drugs, uncontrolled diabetics, and advanced AIDS patients, are at an elevated risk 
for infection, especially deep tissue invasion [3,4]. In addition, patients with invasive fungal infections 
have increased rates of mortality, as well as extended lengths of hospitalization and increased costs 
associated with their medical care [5]; a study performed by Menzin et al. estimated an additional 
735,000 hospital days and $1.89 billion in hospital expenses annually in the United States alone due to 
invasive fungal infections [5].  
Such  medical  conditions  are  commonly  triggered  by  the  inhalation  of  mold  spores  or  hyphal 
fragments, which contain secondary metabolites, called mycotoxins [2]. Mycotoxins play a variety of 
roles in disease, ranging from carcinogens to immunosuppressants, and are produced mainly by two 
fungal species: Aspergillus and Penicillium [6]. Aspergillus species produce large numbers of air-borne 
spores,  which  infect  humans  through  inhalation  and  cause  chronic  mycetoma  and  invasive 
aspergillosis, in addition to the previously discussed conditions [6]. One such Aspergillus species, 
called  Aspergillus  amstelodami,  has  been  shown  to  produce  multiple  toxins,  including  Patulin, 
Ochratoxin A and Sterigmatocystin, as well as elicit symptoms of decreased weight, hair loss, and 
decreased activity in murine subjects upon exposure [7]. 
With the health risks of Aspergillus species well-defined, the need for positive identification of 
mold spores in an effort to reduce or eliminate the health risks associated with prolonged exposure still 
remains. One mode of detection includes monitoring inherent fluorescence of mold spores [8-11]. 
Intense  autofluorescence  from  fungi  following  exposure  to  ultraviolet  light  has  been  reported  by 
several research groups [12,13]. Interestingly, each fungus has a characteristic emission spectrum [12], 
which is dependent upon chemical structure of the endogenous fluorophores present within the cell 
wall  [14];  however,  intrinsic  autofluorescence  of  biological  samples  is  not  fully  understood  [14]. 
Although bioparticle detection via autofluorescence affords real-time analysis [15], such an approach 
lacks  specificity  due  to  numerous  non-hazardous  autofluorescent  biomolecules  that  can  obscure 
emission profiles of targets of interest. Sensors 2011, 11  
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In  contrast,  we  propose  a  fluorescence  resonance  energy  transfer  (FRET)-based  detection  
approach involving fluorescent quantum dots (QDs). QDs hold several advantageous properties for 
labeling applications, such as superior stability against photobleaching in comparison to traditional 
fluorophores [16,17], compatibility with aqueous environments necessary for biological use [16,18], 
and capability to concurrently use multiple QDs with different emission wavelengths to produce a 
multiplexed system [16]. QDs can also be linked to biomolecules, such as antibodies,  to produce 
biosensors capable of fast, sensitive, and specific biological target detection [19]. Such QD-antibody 
conjugates can be utilized as donors in  FRET-based systems  with organic quenchers as acceptors  
for  simple  and  accurate  target  identification  [20-22].  Several  FRET-based  biosensors  have  been 
successfully  produced,  which  operate  according  to  the  following  mechanism  (Figure  1):  (1)  a 
quencher-labeled analyte is prebound within the recognition site of the conjugated antibody resulting 
in  FRET  quenching  of  QD  fluorescence,  then  (2)  the  addition  of  target  analyte  displaces  the  
quencher-labeled analyte, which creates an optical signal through restoration of QD fluorescence in a 
concentration-dependent manner [21,22].  
Figure 1. Mechanism of Mold Detection. The initial biosensor complex is formed when a 
quencher-labeled  analyte  is  bound  by  the  antigen-binding  site  of  the  QD-conjugated 
antibody; when excited, the QD will transfer its energy through FRET to the quencher 
molecules due to their close proximity. Upon addition of the target analytes, displacement 
of the quencher-labeled analytes causes disruption of FRET, which translates to increased 
QD donor emission signal. 
 
 
We have developed a system that mimics previous FRET-based QD biosensors in respect to the 
mechanism of action employed; however, our system is specifically designed for the detection of mold 
spores in solution. As with all FRET systems, several parameters determine the rate and efficiency of 
energy transfer, including: (1) quantum yield of the energy donor, (2) spectral overlap of the donor’s 
emission spectrum with the acceptor’s absorption spectrum, (3) orientation of the donor and acceptor 
transition dipoles, and (4) the distance between the donor and acceptor molecules [14,23]. In addition 
to these classical parameters, it was also necessary to address the issue of mold spore autofluorescence 
to obtain an optimal fluorescence signal. FRET experiments with cell biological samples are frequently 
hindered by poor signal-to-noise ratios, which forces researchers to analyze results in terms of ―FRET‖ 
or  ―no  FRET‖  [23].  This  study  describes  optimization  and  characterization  of  a  FRET-based 
displacement immunoassay capable of sensitive and rapid biological target detection and identification.  Sensors 2011, 11  
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2. Experimental Section 
2.1. Apparatus and Materials 
Solution fluorescence measurements were performed using the Fluoromax 4 spectrofluorometer 
from Horiba Jobin Yvon (Edison, NJ, USA) with quartz cuvettes from Starna Cells (Atascadero, CA, 
USA). Fluorescence measurements of sandwich immunoassays were taken with Tecan Infinite M1000 
plate reader (Durham, NC, USA). Anti-Aspergillus monoclonal detection antibody (IAQ-8602) and 
capture  antibody  (IAQ-8601)  was  obtained  from  Alexeter  Technologies  (Rockford,  IL,  USA).  
Qdot  625  Antibody  Conjugation  kits  (A10197),  Qdot  ITK  (PEG)  quantum  dots  (Q21541MP, 
Q21531MP, Q21501MP, A10200, Q21521MP, and Q21561MP), QuantiT protein assays (Q33210), 
and Lo bind PCR tubes were obtained from Invitrogen Corporation (Carlsbad, CA, USA). All mold 
spores were produced by and purchased from Assured Bio Labs, LLC (Oak Ridge, TN, USA). Black 
Hole Quencher (BHQ)-2 (BHQ-2000S-5) and BHQ-3 (BHQ-3000S-5) were obtained from Biosearch 
Technologies  (Novato,  CA,  USA).  Cy5  mono  amine  reactive—NHS-ester  dye  (PA25001)  was 
obtained from GE Lifesciences (Piscataway, NJ, USA). Zeba Spin desalting columns (7k MWCO,  
2 mL) (89890) were purchased from Pierce-Thermo Scientific (Rockford, IL, USA). Amicon Ultra-4 
Ultracel-PL membrane filters (100 kDa, 2 mL) were obtained from Millipore (Billerica, MA, USA). 
White Corning Costar high binding polystyrene and NBS—low binding 96-well plates were purchased 
from Fisher Scientific (Pittsburgh, PA, USA). PBS (0.01 M Phosphate Buffer Saline, 138 mM NaCl, 
2.7 mM KCl, pH7.4) (P3813), DMSO (D8418), Thermalseal film, Bovine Serum Albumin (BSA) 
(A7030),  and  polypropylene  slip  tip  syringes  (1  mL,  3  mL)  were  purchased  from  Sigma-Aldrich  
(St. Louis, MO, USA). 
2.2. QD-Antibody Conjugation 
QD-antibody conjugation was performed according to the Qdot Antibody Conjugation Kit procedure 
from  Invitrogen.  Briefly,  10  mM  succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate 
crosslinker (SMCC) was equilibrated to 37 ° C for 15 min. Afterwards, 14 µL of thawed SMCC was 
added  to  125  µL  of  4  µ M  amine-derivatized,  polyethylene  glycol  (PEG)-coated  CdSe/ZnS  Qdot 
nanocrystals; the solution was vortexed briefly and incubated for 1 h at room temperature in the dark. 
After 30 min, 300 µ L of 1 mg/mL IgG antibody was activated with 20 mM dithiothreitol (DTT), 
vortexed  briefly,  and  incubated  for 30  min  at  room temperature in  the  dark. Both solutions were 
desalted, and 500 µL of each solution was collected in the same tube; during the 1 h reaction, thiols 
present  on  the  reduced  antibodies  were  coupled  to  reactive  maleimide  groups  present  on  the  
SMCC-activated nanocrystals. The reaction was quenched with 10 µL of 10 mM 2-mercaptoethanol 
for  30  min.  The  conjugate  was  then  concentrated  to  a  final  volume  of  40  µL  by  centrifuging  at  
7,000 rpm (4,700 g) for ~15 min with 50 kDa MWCO filters. The concentrated conjugate was purified 
using a separation column; ten drops or ~200 µL of conjugate was collected and stored at 4 ° C. 
   Sensors 2011, 11  
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2.3. Quantification of Antibody:QD Ratio 
The concentration and antibody:QD ratio of the conjugate was analyzed using UV-Vis spectroscopy 
and QuantiT protein assay from Invitrogen. The conjugate was diluted 1:200 with PBS and analyzed in 
triplicate for absorbance at 608 nm using a Cary UV-Vis spectrometer. QD concentration, which was 
assumed to represent conjugate concentration, was calculated using Beer’s law: 
                
where, ε = 500,000 M
−1cm
−1 for 625 QDs at the absorbance maximum of 608 nm, c = concentration, 
DF  =  dilution  factor,  and  l  =  path  length.  Antibody  concentration  of  the  conjugate  solution  was 
determined according to the QuantiT protein assay protocol; two microliters of conjugate was added to 
198 µ L of working solution and incubated for 15 min. Triplicate readings from a Qubit fluorometer 
were averaged to calculate the antibody concentration in units of mg/mL, which was then converted to 
units of µ M assuming antibody molecular weight to be 150,000 g/mol. The average antibody:QD ratio, 
calculated with the molar concentrations of both components, was compared to the ideal 3–4:1 ratio 
reported by Invitrogen. 
2.4. Reduction of Spore Autofluorescence 
Aspergillus mold species (A. flavus, A. fumigatus, P. brevicompactum, and P. chyrosegenum) at  
10
6  spores/mL  concentration—with  the  exception  of  A.  niger  and  A.  amstelodami,  which  were  
5 ×  10
5 spores/mL and 8.9 ×  10
5 spores/ml, respectively—and solutions of 4 nM QDs were excited at 
350–550 nm in 25 nm increments; emission spectra was measured from 400–750 nm. QD emission 
intensities were divided by the emission intensity of the most autofluorescent mold species at that 
QD’s wavelength to create a signal-to-noise ratio.  
2.5. Sandwich Immunoassay 
Sandwich  immunoassays  were  performed  to  analyze  spore  reactivity  with  the  anti-Aspergillus 
detection antibody. Costar flat-bottom, high binding, white polystyrene 96-well plates were coated 
with 50 µL of 10 µ g/mL anti-Aspergillus capture antibody in PBS and incubated overnight at 4 ° C. 
The solution was removed, and wells were washed 4×  with 200 µ L of water. Two hundred microliters 
of  blocking  solution  (1%  BSA  in  PBS)  was  added  to  each  well  and  incubated  for  1  h  at  room 
temperature. Blocking solution was removed, and the wells were loaded with 50 µL of diluted mold 
species, including A. flavus, A. fumigatus, A. niger, A. amstelodami, Alternaria alternata, Penicillium 
variable, Rhizopus stolonifer, and Cladosporium cladosporiodes II, prepared in PBS with 0.1% BSA, 
which were incubated for 1 h at room temperature. The solution was removed, and wells were washed 
4×  with 200 µL of PBS. Five hundred microliters of 1 mg/mL Anti-Aspergillus detection antibody was 
reacted with one vial of Cy5 monodye dissolved in 50 µ L DMSO for 30 min in the dark. Meanwhile, a 
2 mL 7k MWCO Zeba spin column was washed 3×  with 1 mL PBS by centrifuging at 1,000 g for  
2–3 min; the antibody-Cy5 reaction was loaded into the Zeba spin column and spun at 1,000 g for  
2–3 min to collect the labeled antibody. The Cy5-labeled detection antibody was prepared for the assay 
by diluting the stock to a final concentration of 10 µ g/mL using PBS containing 0.1% BSA. Fifty Sensors 2011, 11  
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microliters of the prepared anti-Aspergillus detection antibody solution was then added to each well 
and incubated for 1.5 h at room temp. The solution was removed, and wells were washed twice with 
200  µ L  of  PBS,  followed  by  two  washes  with  200  µL  of  water.  Wells  were  dried  with  air  and 
measured for Cy5 fluorescence using a fluorescence plate reader. 
2.6. Quenching Efficiency Experiments 
Two hundred microliters of 10
6 spores/mL A. fumigatus was labeled with 25 µ g/mL of the quencher 
species, BHQ-3, for 2 h at room temperature or overnight at 4 ° C. BHQ-3-labeled and unlabeled spores 
were then washed twice by centrifuging at 13,000 rpm (16,200 g) for 10 min, aspirating the supernatant, 
and resuspending with 50 µL of PBS. One hundred picoliters of QD-antibody conjugate was added to 
both  the  BHQ-3-labeled  and  unlabeled  spores  and  incubated  for  30  min.  The  conjugate-spore 
complexes were washed as before and suspended to a final volume of 200 µL with PBS. The samples 
were excited at 450 nm, and emission spectra were measured from 575–675 nm. Intensities at 625 nm 
of  BHQ-3-labeled  and  unlabeled  samples  were  used  to  calculate  FRET  quenching  efficiency  as 
follows: 
                
where, F’D is the donor emission intensity with the presence of the energy acceptor (BHQ-3-labeled 
spores)  and  FD  is  the  donor  emission  intensity  in  the  absence  of  the  energy  acceptor  (unlabeled 
spores). 
2.7. Displacement Immunoassay 
BHQ-3-labeled A. fumigatus was prepared as previously described in Section 2.6. Five microliters 
of QD-antibody conjugate was added for every 10
6 quenched spores and incubated for 30 min. The  
A. fumigatus-BHQ-3-QD-antibody complex was washed as before and suspended to a final calculated 
volume to accommodate 250 µ L for every 10
6 spores; 50 µL aliquots were spun down and resuspended 
immediately before use. Aliquoted volumes of A. fumigatus-BHQ-3-QD-antibody complex were added 
to 150 L of A. amstelodami samples at concentrations of 10
2–10
5 spores/mL and incubated for 10 min 
to allow displacement to occur. Samples were excited at 450 nm, and emission spectra were analyzed 
from 575–675 nm. Time-based displacement immunoassays were performed as described with the 
exception of the 10 min incubation period; instead, samples were analyzed immediately by reading 
peak emission intensity every 20 s over a 15 min time period. 
3. Results and Discussion 
3.1. QD-Antibody Conjugate Characterization 
Purification of QD-antibody conjugates was achieved by gravity flow size-exclusion chromatography 
according to the Invitrogen protocol. To confirm that antibodies were present in the eluted fraction, 
and therefore, properly conjugated to QDs, QD-antibody conjugates were analyzed using Invitrogen’s 
QuantiT  protein  assay.  Additionally,  QD  composition  of  the  eluted  fraction  was  characterized  by  
UV-Vis spectroscopy, which indicated that QD-antibody conjugate concentration was 1.48 µ M on Sensors 2011, 11  
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average  (Table  1).  Concentration  of  antibodies  and  QDs  in  the  eluted  fraction  suggested  that  
QD-antibody conjugates contained ~4.2 antibodies for every QD; however, this antibody:QD ratio 
varied  across  multiple  conjugation  reactions,  perhaps  due  to  slight  differences  in  the  volume  of 
activated QDs and reduced antibodies that was collected during each trial. Antibody:QD ratios and 
conjugate  concentration  were  routinely  analyzed  for  quality  control  following  each  conjugation 
procedure  to  verify  that  QD-antibody  conjugates  were  properly  formed  and  purified.  Conjugate 
batches  with  significantly  increased  antibody:QD  ratios,  such  as  batch  8  (Table  1),  indicated  the 
presence  of  unconjugated  antibodies  in  solution  and  were  discarded;  these  excess  antibodies  can 
compete  to  bind  target  during  the  displacement  immunoassay  and  therefore  negatively  impact 
detection sensitivity. Excess, unconjugated antibodies present in such batches may be removed using 
size-exclusion  high  performance  liquid  chromatography  (HPLC),  although  this  method  was  not 
applied in this study. Conjugate batches whose concentration varies significantly from the average, 
such as batch 5 (Table 1), were adjusted to maintain consistent sensor complex formation. 
Table 1. Composition of QD-antibody Conjugates. The [Ab]:[QD] ratio was calculated by 
dividing the antibody concentration of conjugate solution by the QD concentration. 
Conjugate 
Batch 
Conjugate 
Concentration (µ M) 
[Ab]:[QD] Ratio 
1  1.3  4.4 
2  1.2  3.6 
3  1.4  3.1 
4  1.1  4.5 
5  2.7  1.5 
6  1.4  2.6 
7  1.7  5.1 
8  1.2  7.3 
9  1.2  5.8 
10  1.6  4.4 
Average  1.48  4.20 
Standard Deviation  0.47  1.75 
3.2. FRET Immunoassay Optimization 
Many mold species have intense autofluorescence, such as A. niger and A. amstelodami, while 
others  including  A.  flavus  and  A.  fumigatus  have  limited  autofluorescence  (Figure  2).  High 
autofluorescence can interfere with fluorescence-based detection systems, so it is important to optimize 
the  assay  conditions  to  minimize  this  potential  interference.  To  determine  optimal  excitation 
wavelength  for  the  FRET  sensor,  QDs  (with  emission  maxima  ranging  from  525–705  nm)  and 
different mold species (A. niger, A. amstelodami, A. flavus, A. fumigatus, P. brevicompactum, and  
P. chyrosegenum) were excited individually at various wavelengths in an attempt to minimize mold 
autofluorescence while maintaining strong QD signal. Peak QD emission intensity was divided by the 
emission intensity of the most autofluorescent mold species at the peak QD wavelength (A. niger or  
A. amstelodami), resulting in signal-to-noise ratios (Table 2). Generally, signal-to-noise ratios for QDs 
peaked when excited with wavelengths beyond 425 nm. Sensors 2011, 11  
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As  expected,  less  autofluorescence  from  the  mold  species  was  observed  as  the  excitation 
wavelength  increased;  according  to  Hairston  et  al.,  shorter  excitation  wavelengths  contain  higher 
energy, and therefore, are more likely to produce fluorescence in different samples (9). The majority of 
QDs  produced  optimal  signal-to-noise  when  excited  at  450  nm;  therefore,  a  450  nm  excitation 
wavelength was chosen for all subsequent experiments. The 625 nm QD consistently produced the 
highest signal-to-noise and was subsequently chosen as the FRET donor. 
Figure  2.  Mold  Spore  Autofluorescence.  Emission  spectra  and  intensity  of  different 
Aspergillus mold species are shown. 
 
Table 2. Signal-to-Noise Produced with Varied Excitation Wavelengths. Signal-to-noise 
ratios  were  calculated  for  six  different  QDs  of  differing  fluorescence  emissions  in  the 
presence of maximum mold spore autofluorescence, at the peak wavelength of each QD of 
interest. Maximum signal-to-noise ratios for each QD are shown in bold. *Emission signal 
of  the  525  nm  QD  was  obscured  when  excited  at  525  nm  due  to  interference  from 
excitation photons. **When excited at 350 nm, the emission signal of the 705 nm QD was 
obstructed by an unexplained peak, possibly contributed by QD-solvent interactions that 
are not well understood. 
Excitation 
Wavelength (nm) 
525 nm  565 nm  605 nm  625 nm  655 nm  705 nm 
350  3.8  27.1  125.2  855.6  584.0  ** 
375  2.4  17.8  83.6  578.4  426.1  196.6 
400  1.2  9.0  42.4  323.7  231.7  130.8 
425  1.2  9.0  44.1  352.5  224.4  180.7 
450  6.0  36.8  177.5  1,687.2  955.1  271.4 
475  6.6  69.9  219.3  1670.6  898.5  173.3 
500  32.6  109.6  201.6  804.6  795.9  230.3 
525  *  62.3  164.8  731.2  735.5  164.4 
550  0.4  123.6  182.5  437.4  574.4  84.5 
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Upon identifying the 625 nm QD as an appropriate FRET donor, two quencher molecules, BHQ-2 
and BHQ-3, were evaluated as suitable FRET acceptors. Sufficient overlap of the emission spectrum 
of the FRET donor and absorption spectra of the FRET acceptor is necessary for efficient  energy 
transfer, and in this case, quenching of the QD donor emission. The BHQ-2 absorption  spectrum 
peaked  from  525–550  nm,  while  BHQ-3  showed  maximal  absorption  from  587–613  nm.  The 
absorption  spectrum  of  BHQ-3  offered  significantly  more  overlap  with  the  625  nm  QD  emission 
spectra, as seen in Figure 3, and was therefore chosen as an appropriate quencher for the FRET system. 
Figure 3. Spectral Overlap of FRET Donor-Acceptor Pair. Emission spectrum of 625 nm 
QD  (FRET  donor)  and  absorption  spectra  of  BHQ-2  and  BHQ-3  (possible  FRET 
acceptors) are shown.  
 
 
For  successful  displacement  to  occur,  as  outlined  in  Figure  1,  the  detection  antibody  must  be 
prebound to a mold species for which it has lower affinity. When a mold species that has relatively 
higher affinity for the antibody is present, equilibrium will drive displacement of the lower affinity 
mode analyte. Sandwich immunoassays were initially performed to characterize the antibody reactivity 
with different mold species and identify appropriate low affinity (quencher-analyte) and high affinity 
(target-analyte) analytes for the displacement immunoassay (Figure 4). Of all the mold spores tested, 
A.  fumigatus  produced  a  maximum  signal-to-noise  of  1.53  when  detected  at  10
7  spores/mL.  In 
comparison, A. amstelodami produced a signal-to-noise of 1.99 with only 8 ×  10
2 spores/mL and 
achieved values as high as 4.67 with 10
5 spore/mL concentration. The ability of A. amstelodami to 
produce high signal-to-noise at comparatively low concentrations indicated that the antibody had high 
affinity for this particular mold species. Therefore, A. amstelodami was chosen as a promising target 
analyte,  while  A.  fumigatus  was  selected  for  the  lower  affinity  quencher-labeled  analyte  for  the  
mold-specific antibody. 
Upon identifying a mold species (A. fumigatus) and quencher molecule (BHQ-3) for use as the 
quencher  analyte,  quenching  efficiency  of  the  FRET  complex  was  analyzed  (Figure  5).  When  
QD-antibody  conjugate  was  bound  to  A.  fumigatus  with  no  BHQ-3,  an  emission  intensity  of  
131,322  units  was  produced.  Emission  intensity  of  the  system  decreased  to  72,228  units  when  
BHQ-3-labeled A. fumigatus was introduced. Average quenching efficiency was calculated to be 0.45, 
demonstrating the functionality of the FRET complex. 
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Figure  4.  Antibody  Reactivity  with  Different  Mold  Spores.  (a)  Anti-Aspergillus  IgG 
Affinity  for  A.  fumigatus.  A.  fumigatus  was  detected  with  anti-Aspergillus  antibody  in 
sandwich format. Signal-to-noise values for various concentrations of A. fumigatus and P. 
variable are shown for comparison. (b) Anti-Aspergillus IgG Affinity for A. amstelodami. 
A.  amstelodami  was  detected  with  anti-Aspergillus  antibody  in  sandwich  format.  
Signal-to-noise values for various concentrations of A. amstelodami and A. alternata are 
shown  for  comparison.  A.  flavus,  A.  niger,  Rhizopus  stolonifer,  and  Cladosporium 
cladosporiodes  II produced signals that were indistinguishable from background noise; 
therefore, they were not included in this figure. 
 
        (a)                 (b) 
Figure 5. Quenching Efficiency of FRET Detection System. Emission intensity of 625 nm 
QD-anti-Aspergillus conjugate bound to A. fumigatus spores labeled (with FRET acceptor) 
or unlabeled (without FRET acceptor) with BHQ-3 is shown.  
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3.3. Displacement Immunoassay 
Having optimized the parameters of the FRET system and verified quenching ability, performance 
of the displacement immunoassay was evaluated (Figure 6). First, the ability of the assay to detect and 
distinguish  different  target  concentrations  was  assessed  (Figure  6(a,b)).  Exposure  to  varied  
A. amstelodami concentrations produced increased QD donor emission intensities, all of which were 
above  baseline  signal.  In  addition, exposure  to  non-targeted  E.  coli  O157:H7  maintained  baseline 
fluorescence, demonstrating selectivity of the immunoassay. The fluorescence signal developed very 
rapidly  upon  exposure  to  target  analyte,  reaching  near  maximum  intensity  in  less  than  5  min  for 
samples of higher target concentration (10
4 and 10
5 spores/mL); all target samples, including 10
3 and 
10
2  spores/mL,  produced  an  immediate  increase  in  signal,  as  shown  by  the  normalized  emission 
intensity  in  Figure  6(c).  Also,  the  QD  donor  emission  intensity  was  found  to  increase  in  a  
dose-dependent manner (Figure 6(d)); as the concentration of A. amstelodami increased, more QD 
donor emission was restored due to displacement of quencher analyte. The lower limit of detection of 
the FRET-based displacement immunoassay was determined to be 10
3 spores/mL as indicated by a 
signal-to-noise of 1.28 (Table 3). This FRET-based displacement immunoassay represents a significant 
improvement over currently available lateral flow immunoassays, which require a minimum of 15 min 
to achieve low end limit of detection of 10
5 spores/mL [24]. Many exposure standards classify indoor 
spore counts exceeding 10
5 per cubic meter as a ―high level‖ of mold contamination, although the 
clinical relevance of this value can be debated due to differences in human susceptibilities and toxicity 
of different mold species [25]. 
It is important to note that although 10
3 spores/mL of A. amstelodami was clearly detected and 
distinguished from other target concentrations, the resulting emission intensity varied among trials. 
Detection  trials  with  high  baseline  fluorescence  (tens  of  thousands  of  intensity  units)  produced 
significantly  higher  intensities  in  the  presence  of  target  compared  to  trials  with  lower  baseline 
fluorescence.  However,  trials  with  lower  baselines  (thousands  of  intensity  units)  produced  more 
distinguishable signal-to-noise values for different target concentrations when normalized with the 
baseline.  Detection  trials  that  used  the  same  batch  of  A.  fumigatus-BHQ-3-QD-antibody  complex 
yielded highly reproducible and consistent QD donor emission signals (see detection trials 6 and 7 in 
Table 3). In addition, trials using A. fumigatus-BHQ-3-QD-antibody complexes that had been prepared 
separately with the same batch of QD-antibody conjugate (detection trials 1–5) produced fairly similar 
signal-to-noise, although an instance of enhanced signal-to-noise was noted in trial 5 (Table 3). These 
observations indicated the importance of normalizing data with the baseline for more accurate analysis, 
as well as identified aspects of the immunoassay that are in need of refinement. 
Signal variation could be due to differences in the antibody:QD ratios of the conjugate batches, as 
well as variation among quencher-labeled analyte-conjugate complexes. It may be possible that the 
number of antibodies conjugated to each QD effects the amount of conjugate that is incorporated into 
the FRET complex during preparation. As more conjugated antibodies are present, quencher-labeled 
analyte may be bound with less conjugate, resulting in fewer QDs present; these FRET complexes 
would have lower overall fluorescence compared to complexes formed using conjugate with a low 
antibody:QD ratio. In contrast, one could argue that all antibody binding sites of the QD-antibody 
conjugate  are  not  initially  bound  by  quencher-labeled  analyte.  Conjugate  batches  with  higher Sensors 2011, 11  
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antibody:QD ratios contain more unoccupied antibody binding sites that bind target analyte without 
influencing energy transfer of the FRET system; subsequently, the donor emission signal is not as 
prominent, producing less signal-to-noise in the presence of target analyte. If methods were developed 
to ensure consistent QD-antibody conjugation, as well as consistent quencher-labeled analyte-conjugate 
complex  formation,  variations  in  quenching  efficiency  and  QD  emission  signal  could  possibly  be 
resolved, facilitating more accurate target quantification and lower detection limits. 
Figure  6.  Detection  of  A.  amstelodami  with  FRET-based  Displacement  Immunoassay.  
(a) Raw Data for Target Detection. Emission Intensity of A. amstelodami concentrations 
and controls are shown. PBS baseline contained sensing complex with PBS instead of a 
target sample. Heat-killed E. coli O157:H7 was used as a negative control. (b) Normalized 
Averaged  Data  for  Target  Detection.  Emission  intensities  were  first  normalized  by 
subtracting the PBS baseline emission intensity and then averaged from multiple trials.  
(c)  Development  of  Emission  Signal  Over  Time.  Fluorescence  intensity  produced  at  
625  nm  by  different  target  concentrations  was  monitored  every  20  s  over  a  period  of  
15 min. Detection data from multiple trials was averaged and normalized by subtracting 
the average PBS baseline emission intensity. (d) Emission Intensity Dependence on Target 
Concentration. Average emission intensity at 625 nm is shown with standard deviation 
error bars. 
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Table  3.  Signal-to-Noise  of  Mold  Spore  Samples  Detected  with  Displacement 
Immunoassay. Signal-to-noise values were calculated by dividing the sample fluorescence 
at 625 nm by the fluorescence produced with PBS only. 
Detection Trial  10
5 spores/mL  10
4 spores/mL  10
3 spores/mL  10
2 spores/mL 
1  2.07  1.65  1.27  1.01 
2  1.73  1.60  1.08  1.01 
3  2.20  1.56  1.12  1.03 
4  2.10  1.69  1.24  1.15 
5  5.21  3.37  1.61  1.31 
6  3.23  2.37  1.35  1.34 
7  3.19  2.38  1.29  0.97 
Average  2.82  2.09  1.28  1.12 
Standard Deviation  1.20  0.67  0.17  0.15 
4. Conclusions 
This study documents the development of a FRET-based QD immunoassay for the detection of  
A. amstelodami. The detection complex was formed by conjugating QDs to antibodies and incubating 
with  quencher  (BHQ-3)-labeled  mold  analytes  that  had  a  lower  affinity  for  the  antibody  than  
A. amstelodami. QD-antibody conjugates were first characterized following production and purification 
in terms of concentration and antibody:QD ratio; these characteristics were used for quality control 
measures.  Complications  attributed  to  mold  autofluorescence  were  minimized  by  adjusting  the 
excitation wavelength used and strategically selecting a QD that produced large signal-to-noise ratios. 
Quenching efficiency was optimized by selecting a FRET donor-acceptor pair with maximal spectral 
overlap. After identifying A. fumigatus and A. amstelodami for use as quencher and target analytes, 
respectively,  performance  of  the  subsequent  FRET  complex  was  analyzed.  The  optimized 
displacement immunoassay detected A. amstelodami concentrations as low as 10
3 spores/mL in five 
minutes or less, while maintaining baseline fluorescence in the presence of 10
5 CFU/mL heat-killed  
E. coli O157:H7 (negative control). However, it may be possible to improve detection sensitivity and 
reduce  signal  variation  by  identifying  a  more  reliable  and  consistent  method  of  QD-antibody 
conjugation and FRET complex formation. If one can control the number of antibodies present on a 
QD, quenching efficiency can be enhanced, translating to lower detection limits and uniform signal 
production. Overall, our FRET-based displacement immunoassay offered extremely rapid, sensitive, 
and selective detection of the fungal species A. amstelodami, representing a significant advancement in 
detection capabilities. In addition, this sensing modality may find great utility in rapid detection and 
identification of other biological agents of interest; the FRET-based QD-antibody biosensor can be 
adapted for such targets by incorporating suitable antibodies and surrogates for specific antigens of 
interest to address detection needs in areas from biological terrorism defense to clinical analysis.  
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